Sanofi
SNY
655 hedge funds and large institutions have $12.9B invested in Sanofi in 2022 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 245 increasing their positions, 185 reducing their positions, and 45 closing their positions.
826% more call options, than puts
Call options by funds: $91.1M | Put options by funds: $9.84M
117% more funds holding in top 10
Funds holding in top 10: 6 → 13 (+7)
89% more first-time investments, than exits
New positions opened: 85 | Existing positions closed: 45
32% more repeat investments, than reductions
Existing positions increased: 245 | Existing positions reduced: 185
5% more funds holding
Funds holding: 623 → 655 (+32)
1% more capital invested
Capital invested by funds: $12.8B → $12.9B (+$132M)
0.48% more ownership
Funds ownership: 19.93% → 20.42% (+0.48%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$567M |
| 2 |
Morgan Stanley
New York
|
+$197M |
| 3 |
Bank of New York Mellon
New York
|
+$121M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$96.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$77.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
-$797M |
| 2 |
HCM
Hamlin Capital Management
New York
|
-$65.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$53.6M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$40.5M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$26.8M |
SNY Hedge Fund Activity: Q2 2022 in Review
655 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2022, worth a combined $12.9B — up 1% from $12.8B a quarter earlier.
Buyers outnumbered sellers: 85 funds opened new SNY positions and 45 closed out — a net gain of 40 holders — while 245 added to existing stakes and 185 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $567M. The largest seller was Dodge & Cox, cutting an estimated $797M.
- 655 institutional investors held Sanofi (SNY) as of Q2 2022, up from 623 in Q1 2022.
- Funds reported $12.9B of Sanofi stock for Q2 2022, up 1% quarter-over-quarter.
- 85 funds opened new Sanofi positions in Q2 2022 and 45 closed out, a net change of +40 holders.
- The largest Sanofi buyer in Q2 2022 was T. Rowe Price Associates, an estimated $567M added.
- The largest Sanofi seller in Q2 2022 was Dodge & Cox, an estimated $797M sold.
Based on aggregated 13F filings for Q2 2022.